Argen X NV (PK)【ARGNF】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Argen X NV (PK) (ARGNF) 銘柄情報

Argen X NV (PK) (ARGNF)

525.6012

0.00

(0.00%)

終了 12月18日 6:00AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

525.6012

買値

245.37

売値

1,459.40

出来高

1

0.00 日の範囲 0.00

341.00 52 週間の範囲 540.4454

時価総額

前日終値

525.6012

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

55,469,387

配当利回り

-

PER

-112.69

1 株当たり利益 (EPS)

-5.32

歳入

1.27B

純利益

-295.05M

セクター

Coml Physical, Biologcl Resh

業界

Coml Physical, Biologcl Resh

ウェブサイト

www.argenx.com

本社

Amsterdam, North Holland, Nld

設立

-

Argen X NV (PK) is listed in the Coml Physical, Biologcl Resh sector of the その他OTC with ticker ARGNF. The last closing price for Argen X NV (PK) was US$525.60. Over the last year, Argen X NV (PK) shares have traded in a share price range of US$ 341.00 to US$ 540.4454.

Argen X NV (PK) currently has 55,469,387 shares in issue. The market capitalisation of Argen X NV (PK) is US$29.15 billion. Argen X NV (PK) has a price to earnings ratio (PE ratio) of -112.69.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	525.6012	525.6012	525.6012	0	0	CS
26	82.7112	18.6753369911	442.89	540.44536	442.89	21	496.95918316	CS
52	97.0012	22.6321045264	428.6	540.44536	341	23	429.30603	CS
156	182.1012	53.0134497817	343.5	540.44536	262.8797	403	323.30884337	CS
260	360.6412	218.62342386	164.96	540.44536	130.00123	7525	147.44828948	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
IBKKFImining Technologies Inc (CE)	US$ 0.05 (4,999,900.00%)	833
WRCDFWirecard AG (CE)	US$ 0.01 (999,900.00%)	250
SLAAFSitios Latinoamerica SAB de CV (PK)	US$ 0.189 (94,400.00%)	21.85k
MIKPMike The Pike Productions Inc (CE)	US$ 0.0002 (19,900.00%)	520k
KBNTKubient Inc (CE)	US$ 0.0002 (19,900.00%)	1.48k
AMHGQAmergent Hospitality Group Inc (CE)	US$ 0.000001 (-100.00%)	76.67k
CLVRClever Leaves Holdings Inc (CE)	US$ 0.000001 (-100.00%)	240
NEPTFNeptune Wellness Solutions Inc (CE)	US$ 0.000001 (-100.00%)	3.72k
ORMTQOrmet Corp (CE)	US$ 0.000001 (-99.99%)	500k
RKIGFReko International Group Inc (PK)	US$ 0.0006 (-99.98%)	100
RDARRaadr Inc (PK)	US$ 0.001 (-28.57%)	320.76M
HMBLHUMBL Inc (PK)	US$ 0.0012 (-4.00%)	311.02M
MMEXMMEX Resources Corporation (PK)	US$ 0.0001 (9,900.00%)	265.88M
EARIEntertainment Arts Research Inc (PK)	US$ 0.0001 (0.00%)	213.32M
CGACCode Green Apparel Corp (PK)	US$ 0.0005 (-16.67%)	125.52M

JMoneyHoops

JMoneyHoops 4分前

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 4分前

KILLAZILLA

KILLAZILLA 5分前

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 5分前

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 6分前

Those people know we can still see them, right?

awesomed007

awesomed007 6分前

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 6分前

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 6分前

Paul Malec of Deer Park, NY

fuagf

Yeps, yeps and yeps. Good ones.

NoMoDo

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 6分前

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 8分前

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 8分前

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 9分前

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 9分前

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 10分前

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 11分前

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 11分前

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 13分前

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 14分前

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 14分前

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 14分前

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 14分前

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

Argen X NV (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約